• Progress in Medical Physics
• /
• v.23 no.4
• /
• pp.269-278
• /
• 2012

Aquaplast Thermoplastic (AT) is a tissue-equivalent oral compensator that has been developed to improve dose uniformity at the common boundary and around the treated area during radiotherapy in patients with head and neck cancer. In order to assess the usefulness of AT, the degree of improvement in dose distribution and physical properties were compared to those of oral compensators made using paraffin, alginate, and putty, which are materials conventionally used in dental imprinting. To assess the physical properties, strength evaluations (compression and drop evaluations) and natural deformation evaluations (volume change over time) were performed; a Gafchromic EBT2 film and a glass dosimeter inserted into a developed phantom for dose verification were used to measure the common boundary dose and the beam profile to assess the dose delivery. When the natural deformation of the oral compensators was assessed over a two-month period, alginate exhibited a maximum of 80% change in volume from moisture evaporation, while the remaining tissue-equivalent properties, including those of AT, showed a change in volume that was less than 3%. In a free-fall test at a height of 1.5 m (repeated 5 times as a strength evaluation), paraffin was easily damaged by the impact, but AT exhibited no damage from the fall. In compressive strength testing, AT was not destroyed even at 8 times the force needed for paraffin. In dose verification using a glass dosimeter, the results showed that in a single test, the tissue-equivalent (about 80 Hounsfield Units [HU]) AT delivered about 4.9% lower surface dose in terms of delivery of an output coefficient (monitor unit), which was 4% lower than putty and exhibited a value of about 1,000 HU or higher during a dose delivery of the same formulation. In addition, when the incident direction of the beam was used as a reference, the uniformity of the dose, as assessed from the beam profile at the boundary after passing through the oral compensators, was 11.41, 3.98, and 4.30 for air, AT, and putty, respectively. The AT oral compensator had a higher strength and lower probability of material transformation than the oral compensators conventionally used as a tissue-equivalent material, and a uniform dose distribution was successfully formed at the boundary and surrounding area including the mouth. It was also possible to deliver a uniformly formulated dose and reduce the skin dose delivery.

• Journal of radiological science and technology
• /
• v.39 no.3
• /
• pp.391-397
• /
• 2016

Stereotactic body radiotherapy is effective technic in radiotherapy for low stage lung cancer. But lung cancer is affected by respiratory so accurately concentrate high dose to the target is very difficult. In this study, evaluated the target volume according to how to take the image. And evaluated the dose by photoluminescence glass dosimeter according to how to contour the volume and respiratory range. As a result, evaluated the 4D CT volume was 10.4 cm3 which was closest value of real size target. And in dose case is internal target volume dose was 10.82, 16.88, 21.90 Gy when prescribed dose was 10, 15, 20 Gy and it was the highest dose. Respiratory gated radiotherapy dose was more higher than internal target volume. But it made little difference by respiratory range. Therefore, when moving cancer treatment, acquiring image by 4D CT, contouring internal target volume and respiratory gated radiotherapy technic would be the best way.

• The Journal of the Korea Contents Association
• /
• v.10 no.5
• /
• pp.343-350
• /
• 2010

We measured the radiation exposure for 55 persons (male: 36, female: 19) who was diagnosed with kidney and ureter stones and received ESWL. The absorbed dose was measured at the organ which is expected to absorb relatively much radiation (kidney, bladder, liver). The radiation dose measurement voltage 80kVp, current of 5mA as a fixed model of the human body by using the Rando phantom with Radiophotoluminescent Glass Dosimeter. Absorbed dose was measured for two times (5 minute and 10 minute, each) and converted to effective dose. Mean number of treatment was 1.8 times (1~4) per patient was the mean time of radiation exposure533 seconds (248-2516). For the treatment of right renal stone, the effective dose of right kidney, left kidney, liver and bladder was 2.458mSv, 0.152mSv, 1.404 mSv and 0.019mSv, respectively. For the treatment of left renal stone, the effective dose of right kidney, left kidney, liver and bladder was 2.496mSv, 0.252mSv, 0.178 mSv, and 0.017mSv, respectively. For the treatment of distal ureter stone, the effective dose of right kidney, left kidney and bladder was 0.009mSv, 0.01mSv and 3.742mSv, respectively.

• Journal of the Korean Society of Radiology
• /
• v.12 no.6
• /
• pp.763-768
• /
• 2018

Although the development of radiation therapy techniques has made the treatment more precise, exposure by radiation is unavoidable beyond the treatment site. In this study, we wanted to evaluate the absorbed dose according to the thickness of the bolus on the opposite side of the treatment in radiation treatment for breast cancer and to analyze the effect of dose reduction. An experiment was conducted on Rando phantom using VMAT treatment methods. Five points of A, B, C, D, and E were selected for the breast opposite the treatment, and when the dosimeters of 5, 10, 15, and 20 mm were used. The highest absorbed dose at point D closest to the treatment point was measured and lowest at point B furthest from the treatment point. The mean absorbed dose was 8.61 cGy When the bolus is not used and 8.10, 7.94, 8.06, and 8.10 cGy Depending on the thickness of the bolus. In this study, bolus was intended to be used to analyze the dose-reducing effects of breasts on the other side of the treatment. The results of the study showed the effect of dose reduction and the appropriate bolus thickness should be set up to reduce the dose in normal tissues.

• Progress in Medical Physics
• /
• v.27 no.2
• /
• pp.86-92
• /
• 2016

An absorbed dose calculation method using a digital phantom is implemented in normal organs. This method cannot be employed for calculating the absorbed dose of tumor. In this study, we measure the S-value for calculating the absorbed dose of each organ and tumor. We inject a radioisotope into a torso phantom and perform Monte Carlo simulation based on the CT data. The torso phantom has lung, liver, spinal, cylinder, and tumor simulated using a spherical phantom. The radioactivity of the actual absorbed dose is measured using the injected dose of the radioisotope, which is Cu-64 73.85 MBq, and detected using a glass dosimeter in the torso phantom. To perform the Monte Carlo simulation, the information on each organ and tumor acquired using the PET/CT and CT data provides anatomical information. The anatomical information is offered above mean value and manually segmented for each organ and tumor. The residence time of the radioisotope in each organ and tumor is calculated using the time activity curve of Cu-64 radioactivity. The S-values of each organ and tumor are calculated based on the Monte Carlo simulation data using the spatial coordinate, voxel size, and density information. The absorbed dose is evaluated using that obtained through the Monte Carlo simulation and the S-value and the residence time in each organ and tumor. The absorbed dose in liver, tumor1, and tumor2 is 4.52E-02, 4.61E-02, and 5.98E-02 mGy/MBq, respectively. The difference in the absorbed dose measured using the glass dosimeter and that obtained through the Monte Carlo simulation data is within 12.3%. The result of this study is that the absorbed dose obtained using an image can evaluate each difference region and size of a region of interest.

• Journal of Digital Convergence
• /
• v.11 no.7
• /
• pp.237-242
• /
• 2013

When abdomen and pelvic were scanned with 128 channel MDCT, the gonadal exposure dose was measured with and without gonadal shield and the obtained images were evaluated. As a result, during abdominal MDCT scan, the gonadal exposure dose was measured $16.5{\pm}0.5$ mGy when the gonad shield was not used, and it was $7.5{\pm}0.3$ mGy when the large gonad shield($650m^2$) was used, which showed the effect of reduction in the gonadal exposure dose by 54%. During pelvic MDCT scan, the gonadal exposure dose was $9.5{\pm}0.3$ mGy when the gonad shield was not used, and it was $2.8{\pm}0.2$ mGy when the large gonard shield($650m^2$) was used, which showed the effect of reduction in the gonadal exposure dose by 70%. The images were obtained when using the gonad shield and when not using it during MDCT scan, and as a result of analyzing them with 5-point Likert scale, in the abdominal image, it was 4.1 points irrespective of whether using the gonad shield or not. And also, in pelvic scan, it was 1.2 points when the gonad shield was used, and 4.1 points when it was not used. With the results above, it is considered that during the abdominal 128-MDCT scan, by using the gonad shield, the images should be obtained without being degraded and the exposure dose must be reduced.

• Journal of the Korean Society of Radiology
• /
• v.15 no.7
• /
• pp.949-956
• /
• 2021

The purpose of this paper is to evaluate whether tungsten nanoparticles have a shielding effect on scattered light generated at high doses as an alternative material to lead used to shield scattered light in electron beam therapy. A plate was manufactured to set the position of the dosimeter and the size of the radiation field to be constant. The glass dosimeter was placed at 12 points, which were 1, 2, and 4 cm apart from the center of the field of 10 × 10 cm² in the cross direction. A total of 12 types of tungsten nanoparticle shields were developed with a thickness of 0.75 mm to 4.00 mm and a size of 10 × 10 cm² using 0.4, 0.75, and 1 mm materials. Using a linear accelerator, measurements were made four times at 6 MeV and four times at 12 MeV, and the dose intensity was investigated at 100 MU. The 4 mm shielding plate showed the highest shielding effect at 1 cm from the irradiation field. The 1 mm shielding plate at 2 cm from the irradiation field had the lowest shielding effect. As the thickness of the tungsten shielding plate increased, the electron beam's shielding effect increased sharply. It was confirmed that tungsten nanoparticles can reduce the amount of scattered light generated by electron beam therapy. Therefore, this study will provide basic data when follow-up studies are conducted on the shielding ability of tungsten nanoparticles.

• Journal of radiological science and technology
• /
• v.39 no.1
• /
• pp.1-11
• /
• 2016

The purpose of this study was to provide resources for medical exposure reduction through evaluation of organ dose and image resolution for lumbar spine around according to the size of the collimator in DR system. The size of the collimator were varied from $8^{\prime\prime}{\times}17^{\prime\prime}$ to $14^{\prime\prime}{\times}17^{\prime\prime}$ by 1" in AP and lateral projection for the lumbar spine radiography with RANDO phantom. The organ dose measured for liver, stomach, pancreas, kidney and gonad by the glass dosimeter. The image resolution was analyzed using the Image J program. The organ dose of around lumbar spine were reduced as the size of the collimator is decreased in AP projection. There were no significant changes decreasing rate whenever the size of the collimator were reduced 1" in the gonad. The organ dose showed higher on liver and kidney near the surface in lateral projection. There were decreasing rate of less than 5% in liver and kidney, but decreasing rate was 24.34% in the gonad whenever the size of the collimator were reduced 1". Organ dose difference for internal and external of collimator measured $549.8{\mu}Gy$ in the liver and $264.6{\mu}Gy$ in the stomach. There were no significant changes organ dose difference that measured $1,135.1{\mu}Gy$ in the gonad. Image Quality made no difference because SNR and PSNR were over than 30 dB when the collimator size is less than $9^{\prime\prime}{\times}17^{\prime\prime}$ on AP projection and $10^{\prime\prime}{\times}17^{\prime\prime}$ on lateral projection. Therefore, we are considered that the recommendations criterion for control of collimator were suggested in order to reduce unnecessary X-ray exposure and to obtain good image quality because lumbar spine radiography contains a lot of peripheral organs rather than other area radiography.

• Proceedings of the Korea Contents Association Conference
• /
• 2014.11a
• /
• pp.233-234
• /
• 2014

하지전신계측검사(low extremity teleography)에서 자세 변화에 따른 중요장기의 방사선량을 측정하고 영상을 비교 분석하여 검사방법에 따른 유용성을 알아보고자 하였다. 대상은 하지전신계측검사를 시행한 성인남자 10명을 대상하였고 촬영조건은 관전압 73 kVp, 관전류량 32 mAs, SID 180 cm로 설정하였다. 방사선량 측정은 란도 팬텀을 이용하여 수정체, 갑상선, 생식선 부위에 유리선량계(ion chamber)를 부착한 후 전후방향자세와 후전방향자세를 각각 5번씩 시행하여 부위별로 방사선량을 측정한 후 Paired T-test로 비교 분석 하였다. 영상평가는 전후방향자세와 후전방향자세를 시행한 영상을 blind test를 실시하여 5점 척도로 평가하였다. 결과적으로 전후방향자세검사에 비해 후전방향자세검사가 수정체 약 6%, 갑상선 약 6%, 생식선에 미치는 방사선량을 약 27% 감소시킬 수 있으며 영상평가에서도 두 그룹 간에 큰 차이가 없어, 하지전신계측검사에서 전후방향자세검사보다 후전방향자세검사가 유용할 것으로 사료된다.

• The Journal of Korean Society for Radiation Therapy
• /
• v.27 no.1
• /
• pp.1-11
• /
• 2015

Purpose : Evaluating absorbed dose related to 2D and 3D imaging confirmation devices Materials and Methods : According to the radiographic projection conditions, absorbed doses are measured that 3 glass dosimeters attached to the centers of 0', 90', 180' and 270' in the head, thorax and abdomen each with Rando phantom are used in field size $26.6{\times}20$, $15{\times}15$. In the same way, absorbed doses are measured for width 16cm and 10cm of CBCT each. OBI(version 1.5) system and calibrated glass dosimeters are used for the measurement. Results : AP projection for 2D imaging check, In $0^{\circ}$ degree absorbed doses measured in the head were $1.44{\pm}0.26mGy$ with the field size $26.6{\times}20$, $1.17{\pm}0.02mGy$ with the field size $15{\times}15$. With the same method, absorbed doses in the thorax were $3.08{\pm}0.86mGy$ to $0.57{\pm}0.02mGy$ by reducing field size. In the abdomen, absorbed dose were reduced $8.19{\pm}0.54mGy$ to $4.19{\pm}0.09mGy$. Finally according to the field size, absorbed doses has decreased by average 5~12%. With Lateral projection, absorbed doses showed average 5~8% decrease. CBCT for 3D imaging check, CBDI in the head were $4.39{\pm}0.11mGy$ to $3.99{\pm}0.13mGy$ by reducing the width 16cm to 10cm. In the same way in thorax the absorbed dose were reduced $34.88{\pm}0.93(10.48{\pm}0.09)mGy$ to $31.01{\pm}0.3(9.30{\pm}0.09)mGy$ and $35.99{\pm}1.86mGy$ to $32.27{\pm}1.35mGy$ in the abdomen. With variation of width 16cm and 10cm, they showed 8~11% decrease. Conclusion : By means of reducing 2D field size, absorbed dose were decreased average 5~12% in 3D width size 8~11%. So that it is necessary for radiation therapists to recognize systematical management for absorbed dose for Imaging confirmation. and also for frequent CBCT, it is considered whether or not prescribed dose for RT refer to imaging dose.